您要查找的是不是:
- Clinical curing rate and the overall survival rate drop with the increasing of the shift rate of lymph nodes. 问题:临床治愈率和整体生存率随淋巴结转移率的增加而降低。
- The survival rate of the extricated victims was 80.4% on the first day, and 1892 victims were extricated with an overall survival rate of 40%. 第一天解救出的受难者存活率是80.;4%25;1892名解救出的受难者总生存率为40%25。
- Even in the late stage of endometrial carcinoma,the 5-year overall survival rate can be improved obviously after the best cytoreduction. 化疗可显著提高子宫内膜癌早期合并高危因素患者的5年生存率,降低晚期子宫内膜癌的远处转移率。
- Restaging during radiotherapy classified 9 patients as stage I, 28 as IIA, 13 as IIB, 5 as IIIA, and 9 as IIIB. The 5-year overall survival rate was 81% and the 5-year relapse-free survival rate 75.8%. 放疗中再分期结果:I期9例;IIA期28例;IIB期13例;IIIA期5例;IIIB期9例。 全组累计5年生存率和无瘤生存率分别为81%25和75.;8%25。
- The 1 -, 2-and 3-year overall survival rate was 67. 2% , 38.7% , 27. 3% , respectively, in IFI group; versus 59. 7% , 25. 6% , 19. 2% in ENI group, with a difference significant in the 2-year overall survival rate between IFI and ENI group (P=0.048). 2、3年总生存率;IFI组分别为67.;2%25、38
- Moreover, patients with higher blood vessels positive area or higher MVD had lower disease free survival rate (DFSR) or overall survival rate (OSR) than those with lower blood vessels positive area or lower MVD. 高血管阳性反应总面积组及高MVD组总生存率(OSR)和无瘤生存率(DFSR)低于低血管阳性反应总面积组和低MVD组(P<0.;005)。
- The premenopausal patients gave DFSR of 72.8% and 35.7% ( P <0.01), and their overall survival rates were 80.7% and 60.6% ( P < 0.05). 绝经前患者的内分泌治疗组和化疗组 5年无病生存率分别为 72 8%25和 35 7%25 (P <0 0 1) ;5年总生存率分别为 80 7%25和 6 0 0%25 (P <0 0 5 )。
- The 10-year overall survival rates were 82% for patients who underwent a radical nephrectomy and 93% for patients who underwent a partial nephrectomy. 接受肾脏完全切除病患的10年整体存活率为82%25,相较于接受部分肾脏切除病患则是93%25。
- Overall survival rates and avoidance of disease progression were strongly correlated with cytogenetic response by 12 months; those with a minimal or no cytogenetic response within the first year faired poorly. 总体生存率和病情恶化停止与患者服药12个月后细胞遗传学反应密切相关,那些在第一年里没有或只有很小细胞遗传学反应的患者预后较差。
- Despite improvements in progression-free survival and overall survival, the problems of relapsing and drug-resisting are still serious and long-term survival rates for patients with advanced epithelial ovarian carcinoma(EOC) remain disappointing. 患者无疾病进展生存时间及总生存时间得以改善,但复发和耐药问题依然严重,长期生存率并未提高。 最近,寻找一种与PTX、铂类均无交叉耐药且疗效确切的药物与之配伍治疗晚期卵巢癌成为热门研究课题。
- Postmenopausal patients in the erdocrine and chemotherapy groups gave discase free survival rates (DFSR) of 78.4% and 45.4% ( P <0.01). Their overall survival rates were 83.3% and 52.9% ( P <0.05). 绝经后患者的内分泌治疗组和化疗组 5年无病生存率分别为 78 4%25和 45 4%25(P <0 0 1) ;5年总生存率分别为 83 3%25和 5 2 9%25 (P <0 0 5 ) ;
- The overall survival rates of the patients with metachronous metastases were better than those with synchronous metastases and the tumor size and number were adverse prognosis factors. 异时性肝转移患者的总体生存率优于同时性肝转移;肿瘤的大小与数目是主要决定预后的不良因素;
- Maternal age affects the baby's survival rate. 母亲的年龄影响婴儿的成活率。
- The 5-year survival rate was 47.2%. 这些病人因多在晚期,5年存活率?有47.;2%25。
- Operative removal can improve the survival rate. 积极的手术切除能提高生存率。
- The flap survival rate was 100%. 成功率为百分之百。
- Median overall survival of all 211 patients was 49.3 months. 所有211名患者的中位总存活数是49.;3个月。
- The weaning survival rate of litter was 69.3%. 选择适宜的代乳;母鼠、仔鼠的存活率为69.;3%25。
- MabThera has revolutionized the treatment of lymphoma and is the first therapy in over 20 years to increase overall survival for aggressive non-Hodgkin's Lymphoma patients. 美罗华 实现了淋巴瘤治疗方面的革命,是20多年来的首个能提高侵袭性非霍奇金氏淋巴瘤患者的总存活率的药物。
- In conclusion, the response rate and overall survival with docetaxel + cisplatin were greater than that seen with VC. 总之,缓解率及总生存在泰索帝+顺铂组比VC组好,在泰索帝+卡铂组与对照组相当。